Does recent tech sell-off signal 'beginning of the end' for turbo-charged rally?

'Big five' tech stocks hit recently

Tom Eckett
clock • 3 min read

Managers have warned recent falls for technology stocks could mark the beginning of a wider sell-off in the sector, as they point to overstretched valuations and concerns about crowded trades.

Shares in the so-called 'big five' technology stocks were hit recently, with Apple down 4%, while Microsoft, Facebook, Alphabet and Amazon lost over 3% each in a day's trading, as a note was published by Goldman Sachs entitled Is FANG Mispriced? According to CNBC, the falls accounted for an overall loss of $97.5bn in market value by Friday close (9 June), marking the worst week for the tech-heavy Nasdaq index so far this year. Meanwhile, US tech stock ETFs suffered outflows of €1.8bn in one day last Monday (12 June), according to ETF analysis platform TrackInsight, although shares hav...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot